Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Tirzepatide is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Clinical studies have documented this increase in heart rate as a common side effect
GLP-1s affect appetite, muscle mass, energy, and multiple metabolic systems over time
Twelve days ago, the Medicare GLP-1 Bridge went live
Geriatric No dosage adjustment is required based solely on age
US$ 28.18
US$ 28.09
US$ 22.28
